Todd A. Huffman
Fundador en Padlock Therapeutics, Inc. .
Relaciones activas
Nombre | Sexo | Edad | Empresas relacionadas | Colaboración |
---|---|---|---|---|
Michael Gilman | M | 69 |
Padlock Therapeutics, Inc.
Padlock Therapeutics, Inc. BiotechnologyHealth Technology Padlock Therapeutics, Inc. develops medicines targeting protein-arginine deiminases. It develops drugs that block the protein-arginine deiminase (PAD) enzymes. The firm leverages the breakthrough science on the role of protein citrullination in disease to develop drugs targeting protein-arginine deiminase (PAD) enzymes. The company was founded by Paul Thompson, Kerri Mowen, Todd A. Huffman and Michael Gilman in January 2014 and is headquartered in Cambridge, MA. | 10 años |
Kerri Mowen | M | - |
Padlock Therapeutics, Inc.
Padlock Therapeutics, Inc. BiotechnologyHealth Technology Padlock Therapeutics, Inc. develops medicines targeting protein-arginine deiminases. It develops drugs that block the protein-arginine deiminase (PAD) enzymes. The firm leverages the breakthrough science on the role of protein citrullination in disease to develop drugs targeting protein-arginine deiminase (PAD) enzymes. The company was founded by Paul Thompson, Kerri Mowen, Todd A. Huffman and Michael Gilman in January 2014 and is headquartered in Cambridge, MA. | 10 años |
James R. Andrews | M | 82 |
The University of Virginia School of Medicine
| - |
Elizabeth L. Anderson | M | 83 |
University of Virginia
| 19 años |
David Grainger | M | 58 |
Padlock Therapeutics, Inc.
Padlock Therapeutics, Inc. BiotechnologyHealth Technology Padlock Therapeutics, Inc. develops medicines targeting protein-arginine deiminases. It develops drugs that block the protein-arginine deiminase (PAD) enzymes. The firm leverages the breakthrough science on the role of protein citrullination in disease to develop drugs targeting protein-arginine deiminase (PAD) enzymes. The company was founded by Paul Thompson, Kerri Mowen, Todd A. Huffman and Michael Gilman in January 2014 and is headquartered in Cambridge, MA. | - |
Kevin R. Lynch | M | - |
The University of Virginia School of Medicine
| - |
Roel Bulthuis | M | - |
Padlock Therapeutics, Inc.
Padlock Therapeutics, Inc. BiotechnologyHealth Technology Padlock Therapeutics, Inc. develops medicines targeting protein-arginine deiminases. It develops drugs that block the protein-arginine deiminase (PAD) enzymes. The firm leverages the breakthrough science on the role of protein citrullination in disease to develop drugs targeting protein-arginine deiminase (PAD) enzymes. The company was founded by Paul Thompson, Kerri Mowen, Todd A. Huffman and Michael Gilman in January 2014 and is headquartered in Cambridge, MA. | 10 años |
Michael Gladstone | M | 37 |
Padlock Therapeutics, Inc.
Padlock Therapeutics, Inc. BiotechnologyHealth Technology Padlock Therapeutics, Inc. develops medicines targeting protein-arginine deiminases. It develops drugs that block the protein-arginine deiminase (PAD) enzymes. The firm leverages the breakthrough science on the role of protein citrullination in disease to develop drugs targeting protein-arginine deiminase (PAD) enzymes. The company was founded by Paul Thompson, Kerri Mowen, Todd A. Huffman and Michael Gilman in January 2014 and is headquartered in Cambridge, MA. | - |
Marian Nakada | M | - |
Padlock Therapeutics, Inc.
Padlock Therapeutics, Inc. BiotechnologyHealth Technology Padlock Therapeutics, Inc. develops medicines targeting protein-arginine deiminases. It develops drugs that block the protein-arginine deiminase (PAD) enzymes. The firm leverages the breakthrough science on the role of protein citrullination in disease to develop drugs targeting protein-arginine deiminase (PAD) enzymes. The company was founded by Paul Thompson, Kerri Mowen, Todd A. Huffman and Michael Gilman in January 2014 and is headquartered in Cambridge, MA. | - |
Paul Thompson | M | - |
Padlock Therapeutics, Inc.
Padlock Therapeutics, Inc. BiotechnologyHealth Technology Padlock Therapeutics, Inc. develops medicines targeting protein-arginine deiminases. It develops drugs that block the protein-arginine deiminase (PAD) enzymes. The firm leverages the breakthrough science on the role of protein citrullination in disease to develop drugs targeting protein-arginine deiminase (PAD) enzymes. The company was founded by Paul Thompson, Kerri Mowen, Todd A. Huffman and Michael Gilman in January 2014 and is headquartered in Cambridge, MA. | - |
Rab Prinjha | M | - |
Padlock Therapeutics, Inc.
Padlock Therapeutics, Inc. BiotechnologyHealth Technology Padlock Therapeutics, Inc. develops medicines targeting protein-arginine deiminases. It develops drugs that block the protein-arginine deiminase (PAD) enzymes. The firm leverages the breakthrough science on the role of protein citrullination in disease to develop drugs targeting protein-arginine deiminase (PAD) enzymes. The company was founded by Paul Thompson, Kerri Mowen, Todd A. Huffman and Michael Gilman in January 2014 and is headquartered in Cambridge, MA. | - |
Nathan Fountain | M | 61 |
The University of Virginia School of Medicine
| - |
Linda Duska | F | - |
The University of Virginia School of Medicine
| - |
Gráfico relacional
Relaciones con varias empresas
Antiguas relaciones
Nombre | Sexo | Edad | Empresas relacionadas | Colaboración |
---|---|---|---|---|
Ryan Berg | M | - |
University of Virginia
| 10 años |
Adam Fassnacht | M | - |
University of Virginia
| 6 años |
Rahul Gorawara | M | - |
University of Virginia
| 5 años |
Zachary Bratun Glennon | M | - |
University of Virginia
| 4 años |
Alexander T. Seals | M | - |
University of Virginia
| 5 años |
Francis Teo | M | - |
University of Virginia
| 6 años |
Edward Shuman | M | - |
University of Virginia
| 9 años |
Scott B Crenshaw | M | - |
University of Virginia
| 6 años |
Kevin Matthew Mixon | M | - |
University of Virginia
| 4 años |
Howard Hechler | M | - |
University of Virginia
| 4 años |
Max Leykin | M | - |
University of Virginia
| 5 años |
Chris Carroll | M | - |
University of Virginia
| 4 años |
Linda S. Tansik | F | - |
RCT BioVentures
RCT BioVentures Investment ManagersFinance RCT BioVentures (RCT BioVentures) is a venture capital subsidiary of Research Corporation Technologies Inc founded in 1987. The firm is headquartered in Tucson, Arizona. | 26 años |
Nitin Chandra | M | - |
University of Virginia
| 9 años |
McGavock Dickinson Dunbar | M | - |
University of Virginia
| 4 años |
Kristina Wilmer | F | - |
University of Virginia
| 7 años |
Ryan Gurney | M | - |
University of Virginia
| 4 años |
Brock Saunders | M | - |
University of Virginia
| 4 años |
William DeVar | M | - |
University of Virginia
| 4 años |
Nick Harris | M | - |
University of Virginia
| 4 años |
Alan Lawrence Broderick | M | - |
University of Virginia
| 4 años |
Tracy Schwartz-Ward | F | - |
University of Virginia
| 4 años |
Richard Middleton Williamson | M | - |
University of Virginia
| 4 años |
Erhan Artuc | M | - |
University of Virginia
| 3 años |
Viraj Didwania | M | - |
University of Virginia
| 4 años |
Chen Feng Song | M | 42 |
University of Virginia
| 4 años |
David Seaman | M | - |
University of Virginia
| 10 años |
Zachary F. Hill | M | - |
University of Virginia
| 4 años |
Ethan James Appleby | M | - |
University of Virginia
| 4 años |
Harrison Segall | M | - |
University of Virginia
| 4 años |
William Flood | M | - |
University of Virginia
| 3 años |
Brian Fairbank | M | - |
University of Virginia
| 4 años |
Tarapore Shahrukh | M | - |
University of Virginia
| 2 años |
Geoffrey Miles | M | - |
University of Virginia
| 4 años |
Diane Banta | F | - |
University of Virginia
| 4 años |
Hanny Akl | M | - |
University of Virginia
| 1 años |
Christos Tsentas | M | 37 |
University of Virginia
| 4 años |
Thaddeus Darden | M | 37 |
University of Virginia
| 4 años |
Dave Olsen | M | - |
University of Virginia
| 1 años |
Ryan Grammer | M | - |
University of Virginia
| 4 años |
Rachel Kropa | F | - |
University of Virginia
| 4 años |
Ed Cao | M | - |
University of Virginia
| 4 años |
Lauren Nanna | F | - |
University of Virginia
| 4 años |
James Edward Bogart | M | - |
University of Virginia
| 4 años |
Jackie Dunklau | F | - |
University of Virginia
| 4 años |
Francis Nathaniel Gotianun | M | 40 |
University of Virginia
| 4 años |
Mesh Lakhani | M | - |
University of Virginia
| 4 años |
Srikripa Devarakonda | M | - |
University of Virginia
| 6 años |
Jed Leidheiser | M | - |
University of Virginia
| 4 años |
Guido DeAscanis | M | - |
University of Virginia
| 2 años |
Jonathan Chou | M | - |
University of Virginia
| 4 años |
Seanan Maranzano | M | - |
University of Virginia
| 4 años |
Tyler Walk | M | - |
University of Virginia
| 4 años |
Jaime Forsyth | F | - |
University of Virginia
| 4 años |
Christopher C. Green | M | - |
University of Virginia
| 3 años |
Peter Chidyllo | M | - |
University of Virginia
| 4 años |
Daniel Lawrence | M | - |
University of Virginia
| 4 años |
Scott B. Luftglass | M | - |
University of Virginia
| 3 años |
Louise M. Bald | F | - |
University of Virginia
| 4 años |
Chad Ellis | M | - |
University of Virginia
| 4 años |
John L. Gainer | M | 85 |
University of Virginia
| 39 años |
David Lonergan | M | - |
RCT BioVentures
RCT BioVentures Investment ManagersFinance RCT BioVentures (RCT BioVentures) is a venture capital subsidiary of Research Corporation Technologies Inc founded in 1987. The firm is headquartered in Tucson, Arizona. | 2 años |
Cody Nystrom | F | - |
University of Virginia
| 4 años |
Philip Giampietro | M | - |
University of Virginia
| 4 años |
Michael F. Farah | M | - |
University of Virginia
| 4 años |
Matthew Mariner | M | - |
University of Virginia
| 4 años |
Kenneth Rollins | M | - |
University of Virginia
| 3 años |
Rosemary Liu | F | - |
University of Virginia
| 4 años |
Zhi Xiong Yan | M | 53 |
University of Virginia
| 2 años |
Noah Charles Perry Greenbaum | M | - |
University of Virginia
| 4 años |
David Proman | M | 41 |
University of Virginia
| 4 años |
Kenneth Suggett George | M | - |
University of Virginia
| 4 años |
Brad Sullivan | M | - |
University of Virginia
| 2 años |
Bradford James Manning | M | - |
University of Virginia
| 4 años |
Evan Ufer | M | - |
University of Virginia
| 4 años |
Ross Baird | M | - |
University of Virginia
| 4 años |
Michael Koban | M | - |
University of Virginia
| 4 años |
Brian Welsh | M | - |
University of Virginia
| 4 años |
James Aldige | M | - |
University of Virginia
| 4 años |
Ali Houshmand | M | - |
University of Virginia
| 2 años |
Daniel Hayden Saunders | M | - |
University of Virginia
| 4 años |
Yumee Song | F | - |
University of Virginia
| 4 años |
Teddy Lamade | M | - |
University of Virginia
| 4 años |
Justin P. Lux | M | - |
University of Virginia
| 4 años |
Pike Howard | M | - |
University of Virginia
| 4 años |
Jagjit Idnani | M | - |
University of Virginia
| 4 años |
Louis Matthews | M | - |
University of Virginia
| 4 años |
Estadísticas
País | Relaciones | % del total |
---|---|---|
Estados Unidos | 96 | 96.00% |
Antigüedad de la relación
Activas
Pasados
Hombre
Mujer
Administradores
Ejecutivos
Origen de las relaciones
- Bolsa de valores
- Insiders
- Todd A. Huffman
- Red Personal